We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
-1.29%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$664M
AUM Growth
-$538M
(-45%)
Cap. Flow
-$484M
Cap. Flow
% of AUM
-72.87%
Top 10 Holdings %
Top 10 Hldgs %
25.32%
Holding
142
New
15
Increased
24
Reduced
58
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Certara
CERT
|
+$11.8M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$11.4M |
| 3 |
Privia Health
PRVA
|
+$10M |
| 4 |
Definitive Healthcare
DH
|
+$9.98M |
| 5 |
Arrowhead Research
ARWR
|
+$7.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Agilent Technologies
A
|
+$17.9M |
| 2 |
Arcus Biosciences
RCUS
|
+$17.7M |
| 3 |
ResMed
RMD
|
+$15.8M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$14.5M |
| 5 |
Evolent Health
EVH
|
+$13.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.16% |
| 2 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARNA
1
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $21.4M | 3.22% |
230,043
-138,356
| -38% | -$9.12M |
|
|
EFTR
2
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $19.7M | 2.97% |
95,310
-20,000
| -17% | -$4.64M |
|
|
OCDX
3
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $18.6M | 2.8% |
870,347
-247,823
| -22% | -$4.88M |
|
|
SYNH
4
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $16.9M | 2.54% |
164,256
-151,350
| -48% | -$14.5M |
|
5
AtriCure
ATRC
$1.67B
| $16.1M | 2.42% |
231,214
-114,803
| -33% | -$8.34M |
|
|
RCM
6
DELISTED
R1 RCM Inc. Common Stock
RCM
| $15.5M | 2.33% |
607,494
-528,595
| -47% | -$12.7M |
|
|
7
Evolent Health
EVH
$522M
| $15.3M | 2.3% |
552,001
-484,637
| -47% | -$13.9M |
|
8
UnitedHealth
UNH
$385B
| $15.2M | 2.29% |
30,300
+1,500
| +5% | +$679K |
|
|
NARI
9
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $14.9M | 2.25% |
163,550
-126,100
| -44% | -$10.8M |
|
10
Arvinas
ARVN
$524M
| $14.6M | 2.2% |
178,213
-130,179
| -42% | -$10.6M |
|
11
Insmed
INSM
$23.3B
| $14.4M | 2.17% |
528,342
-360,358
| -41% | -$10.3M |
|
|
FOLD
12
DELISTED
Amicus Therapeutics
FOLD
| $14.4M | 2.16% |
1,242,882
-1,167,722
| -48% | -$13M |
|
13
Johnson & Johnson
JNJ
$624B
| $12.7M | 1.92% |
74,500
| – | – |
|
14
Pfizer
PFE
$143B
| $12.3M | 1.85% |
208,400
+87,500
| +72% | +$4.34M |
|
15
Inspire Medical Systems
INSP
$1.46B
| $11.9M | 1.79% |
51,650
| – | – |
|
16
Tenet Healthcare
THC
$17.1B
| $11.7M | 1.76% |
143,000
+54,000
| +61% | +$3.95M |
|
|
17
Arcus Biosciences
RCUS
$3.74B
| $11.5M | 1.73% |
283,210
-455,800
| -62% | -$17.7M |
|
18
Thermo Fisher Scientific
TMO
$213B
| $11.4M | 1.72% |
17,150
-1,500
| -8% | -$937K |
|
19
Fate Therapeutics
FATE
$294M
| $11.3M | 1.7% |
193,160
| – | – |
|
|
MRTX
20
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $11.1M | 1.67% |
75,837
+73,286
| +2,873% | +$11.4M |
|
|
TPTX
21
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $10.5M | 1.58% |
219,750
+83,100
| +61% | +$3.72M |
|
22
PTC Therapeutics
PTCT
$6.51B
| $10.4M | 1.57% |
262,291
+10,000
| +4% | +$383K |
|
|
AGTI
23
DELISTED
Agiliti Inc
AGTI
| $10.4M | 1.57% |
449,747
-527,522
| -54% | -$11.6M |
|
|
24
Privia Health
PRVA
$3.15B
| $10.4M | 1.56% |
+401,629
| New | +$10M |
|
25
Alignment Healthcare
ALHC
$4.13B
| $10.3M | 1.54% |
729,452
+328,307
| +82% | +$5.75M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Sectoral Asset Management held 142 positions worth $664M, down 45% from $1.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Sectoral Asset Management withdrew a net $484M in Q4 2021, closing 34 positions and reducing 58 holdings. Its most notable exit was ResMed, an estimated $15.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 95% a quarter earlier, followed by Industrials.
Against the trend, Sectoral Asset Management opened a new position in Certara worth $9.96M.
- Sectoral Asset Management's largest Q4 2021 buy was Certara: 350,438 shares worth $9.96M.
- Sectoral Asset Management added most to Mirati Therapeutics, Inc. Common Stock in Q4 2021, an estimated $11.4M increase.
- Sectoral Asset Management's biggest Q4 2021 reduction was Agilent Technologies, cutting an estimated $17.9M.
- Sectoral Asset Management fully exited ResMed in Q4 2021, selling an estimated $15.8M.
- Sectoral Asset Management's ten largest holdings make up 25% of its $664M portfolio in Q4 2021.
- Sectoral Asset Management opened 15 new positions and closed 34 in Q4 2021.
- Sectoral Asset Management's portfolio value fell 45% quarter-over-quarter to $664M.
Based on Sectoral Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.